The evaluation and preparation of the patient for lung volume reduction surgery

Proceedings of the American Thoracic Society

Volumn 5, Issue 4, 2008, Pages 427-431

  DeCamp Jr , Malcolm M ^a   Lipson, David ^b   Krasna, Mark ^c   Minai, Omar A ^d   McKenna Jr , Robert J ^e   Thomashow, Byron M ^f  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c St Joseph's Medical Center   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

^f New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

Chronic obstructive pulmonary disease; Emphysema; Lung volume reduction surgery; Preoperative evaluation; Pulmonary rehabilitation

Indexed keywords

FLUTICASONE PROPIONATE PLUS SALMETEROL; PREDNISONE; TIOTROPIUM BROMIDE;

ARTERIAL BLOOD; BLOOD GAS ANALYSIS; BODY MASS; BODY PLETHYSMOGRAPHY; CARDIOPULMONARY EXERCISE TEST; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; HIGH RISK PATIENT; HUMAN; LUNG DIFFUSION CAPACITY; LUNG EMPHYSEMA; LUNG FUNCTION; LUNG RESECTION; LUNG VOLUME; OXYGEN THERAPY; PREOPERATIVE EVALUATION; PULMONARY REHABILITATION; QUALITY OF LIFE; REVIEW; SCREENING; SPIROMETRY; SURGICAL RISK; WALKING;

BLOOD GAS ANALYSIS; EXERCISE TEST; HUMANS; PATIENT SELECTION; PNEUMONECTOMY; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PULMONARY EMPHYSEMA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY FUNCTION TESTS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 43449096383     PISSN: 15463222     EISSN: None     Source Type: Journal    
DOI: 10.1513/pats.200707-087ET     Document Type: Review

References (25)

1. Naunheim KS, Wood DE, Krasna MJ, DeCamp MM, Ginsburg ME, McKenna RJ, Criner GJ, Hoffman EA, Sternberg AL, Descamps C, for the National Emphysema Treatment Trial Research Group. Predictors of operative mortality and cardiopulmonary morbidity in the National Emphysema Treatment Trial. J Thorac Cardiovasc Surg 2006;131:43-53.
2. National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung volume reduction surgery. N Engl J Med 2001;345:1075-1083.
3. National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348:2059-2073.
4. Phurrough SE, Salive M, Baldwin JF, Cano C (Centers for Medicare and Medicaid Services, Baltimore, MD). Memo to: CMS administrative file [Internet]. 2005 Nov 17. [accessed 2008 Jan 2]. Available from: http://www.chestnet.org/ practice/pm/lungmemo.php
5. De Rose J, Argenziano M, El-Amir N, Jellen P, Gorenstein L, Steinglass K, Thomashow B, Ginsburg M. Lung reduction operation and resection of pulmonary nodules in patient with severe emphysema. Ann Thorac Surg 1998;65:314-318.
6. McKenna RJ Jr, Fischel RJ, Brenner M, Gelb AF. Combined operations for lung volume reduction surgery and lung cancer. Chest 1996;110:885-888.
7. Warner MA, Offord KP, Warner ME, Lennon RL, Conover MA, Jansson-Schumacher U. Role of preoperative cessation of smoking and other factors in postoperative pulmonary complications: a blinded prospective study of coronary bypass patients. Mayo Clin Proc 1989;64:609-616.
8. Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res 2003;5:13-25.
9. Stoller JK, Gildea TR, Ries AL, Meli YM, Karafe MT, for the National Emphysema Treatment Trial Research Group. Lung volume reduction surgery in patients with emphysema and alpha-1 antitrypsin deficiency: experience in the National Emphysema Treatment Trial. Ann Thorac Surg 2007;83:241-251.
10. Arcasoy SM, Christie JD, Ferrari VA, Sutton MS, Zisman DA, Blumenthal NP, Pochettino A, Kotloff RM. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003;167:735-740.
11. Fisher M, Hassoun P, Criner G, Scharf S, Fessler HE. Accuracy of Doppler echocardiography for pulmonary hypertension in the National Emphysema Treatment Trial. Am J Respir Crit Care Med 2004;169:A178.
12. Eaken EG, Resnikoff PM, Prewitt LM, Ries AL, Kaplan RM. Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire: University of California, San Diego. Chest 1998;113:619-624.
13. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54:581-586.
14. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-1012.
15. Lederer DJ, Thomashow BM, Ginsburg ME, Austin JHM, Bartels MN, Yip CK, Jellen PA, Brogan FL, Kawut SM, Maxfield RA, et al. Lung volume reduction surgery for pulmonary emphysema: Improvement in the body mass index, airflow obstruction, dyspnea, and exercise capacity index after 1 year. J Thorac Cardiovasc Surg 2007;133:1434-1438.
16. Imfeld S, Bloch KE, Weder W, Russi EW. The BODE index after lung volume reduction surgery correlates with survival. Chest 2006;129:873-878.
17. Ries AL, Make BJ, Lee SM, Krasna MJ, Bartels M, Crouch R, Fishman AP, for the National Emphysema Treatment Trial. The effects of pulmonary rehabilitation in the National Emphysema Treatment Trial. Chest 2005;128:3799-3809.
18. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [Internet]. Bethesda (MD): National Heart, Lung, and Blood Institute; 2007 [accessed 2008 Jan 02]. Available from: http://www.goldcopd.org/ Guidelineitem.asp?11=2&12=1&intId=989
19. American Thoracic Society/European Respiratory Society Task Force. Standards for the diagnosis and management of patients with COPD [Internet]. Version 1.2. New York: American Thoracic Society; 2004 [updated 2005 Sep 8; accessed 2008 Jan 2]. Available from: http://www.thoracic.org/go/copd
20. Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, et al.; Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2007;146:545-555.
21. Barr RG, Celli BR, Martinez FJ, Ries AL, Rennard SI, Reilly JJ, Sciurba FC, Thomashow BM, Wise RA, for the COPD Resource Network. Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey. Am J Med 2005;118:12:1415.
22. Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J Suppl 2003;41:46s-53s.
23. Fan VS, Ramsey SD, Make BJ, Martinez FJ, for the NETT Research Group. Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD. COPD 2007;4:29-39.
24. Naunheim KS, Wood DE, Mosenifar Z, Sternberg AL, Criner G, DeCamp MM, Deschamps C, Martinez FJ, Tonascia J, Fishman AP, for the National Emphysema Research Group. Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg 2006;82:431-443.
25. DeCamp MM, Blackstone EH, Naunheim KS, Krasna MJ, Wood DE, Meli YM, McKenna RJ, for the NETT Research Group. Patient and surgical factors influencing air leak after lung volume reduction surgery: lessons learned from the National Emphysema Treatment Trial. Ann Thorac Surg 2006;82:197-207.